<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alexander KL</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Crohn&amp;apos;s and Colitis Foundation of America</funding><funding>Kenneth Rainin Foundation</funding><funding>NIAID NIH HHS</funding><funding>Crohn's &amp; Colitis Foundation</funding><funding>National Institutes of Health</funding><funding>U.S. Department of Veterans Affairs</funding><funding>CSRD VA</funding><pagination>522-535.e6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8489510</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>161(2)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Crohn's disease and ulcerative colitis are characterized by dysregulated adaptive immune responses to the microbiota in genetically susceptible individuals, but the specificity of these responses remains largely undefined. Therefore, we developed a microbiota antigen microarray to characterize microbial antibody reactivity, particularly to human-derived microbiota flagellins, in inflammatory bowel disease.&lt;h4>Methods&lt;/h4>Sera from healthy volunteers (n = 87) at the University of Alabama at Birmingham and from patients recruited from the Kirklin Clinic of University of Alabama at Birmingham Hospital, including patients with Crohn's disease (n = 152) and ulcerative colitis (n = 170), were individually probed against microbiota bacterial flagellins of both mouse an</pubmed_abstract><journal>Gastroenterology</journal><pubmed_title>Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.</pubmed_title><pmcid>PMC8489510</pmcid><funding_grant_id>32655</funding_grant_id><funding_grant_id>I01 CX001530</funding_grant_id><funding_grant_id>T32 AI007051</funding_grant_id><funding_grant_id>523929</funding_grant_id><funding_grant_id>CX0001530</funding_grant_id><funding_grant_id>AI007051</funding_grant_id><funding_grant_id>KRA000010</funding_grant_id><pubmed_authors>Alexander KL</pubmed_authors><pubmed_authors>Reif M</pubmed_authors><pubmed_authors>Duck LW</pubmed_authors><pubmed_authors>Zhao Q</pubmed_authors><pubmed_authors>Rosenberg AF</pubmed_authors><pubmed_authors>Mannon PJ</pubmed_authors><pubmed_authors>Elson CO</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.</name><description>&lt;h4>Background and aims&lt;/h4>Crohn's disease and ulcerative colitis are characterized by dysregulated adaptive immune responses to the microbiota in genetically susceptible individuals, but the specificity of these responses remains largely undefined. Therefore, we developed a microbiota antigen microarray to characterize microbial antibody reactivity, particularly to human-derived microbiota flagellins, in inflammatory bowel disease.&lt;h4>Methods&lt;/h4>Sera from healthy volunteers (n = 87) at the University of Alabama at Birmingham and from patients recruited from the Kirklin Clinic of University of Alabama at Birmingham Hospital, including patients with Crohn's disease (n = 152) and ulcerative colitis (n = 170), were individually probed against microbiota bacterial flagellins of both mouse an</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2026-05-08T11:29:45.291Z</modification><creation>2025-04-19T06:02:51.344Z</creation></dates><accession>S-EPMC8489510</accession><cross_references><pubmed>33844987</pubmed><doi>10.1053/j.gastro.2021.03.064</doi></cross_references></HashMap>